MiRagen Therapeutics Lands $7,000,000 Series B Round

  • Feed Type
  • Date
    7/1/2014
  • Company Name
    MiRagen Therapeutics
  • Mailing Address
    6200 Lookout Rd Boulder, CO 80301 USA
  • Company Description
    Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
  • Website
    http://www.miragentherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Leverone said the extension with Servier is independent of the latest Series B funding installment. That money, he said, will be used to advance MiRagen assets that are not part of the Servier deal.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy